Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions
Authors:
Open Access
- 1 December 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
Eosinophilic esophagitis (EoE) is an antigen-driven disease associated with epithelial barrier dysfunction and chronic type 2 inflammation. Eosinophils are the defining feature of EoE histopathology but relatively little is known about their role in disease onset and progression. Classically defined as destructive, end-stage effector cells, eosinophils (a resident leukocyte in most of the GI tract) are increasingly understood to play roles in local immunity, tissue homeostasis, remodeling, and repair. Indeed, asymptomatic esophageal eosinophilia is observed in IgE-mediated food allergy. Interestingly, EoE is a potential complication of oral immunotherapy (OIT) for food allergy. However, we recently found that patients with peanut allergy may have asymptomatic esophageal eosinophilia at baseline and that peanut OIT induces transient esophageal eosinophilia in most subjects. This is seemingly at odds with multiple studies which have shown that EoE disease severity correlates with tissue eosinophilia. Herein, we review the potential role of eosinophils in EoE at different stages of disease pathogenesis. Based on current literature we suggest the following: (1) eosinophils are recruited to the esophagus as a homeostatic response to epithelial barrier disruption; (2) eosinophils mediate barrier-protective activities including local antibody production, mucus production and epithelial turnover; and (3) when type 2 inflammation persists, eosinophils promote fibrosis.Keywords
This publication has 209 references indexed in Scilit:
- Eosinophilic esophagitis: Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatmentJournal of Allergy and Clinical Immunology, 2012
- Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic AcidJournal of Biological Chemistry, 2012
- Antigen Presentation and MHC Class II Expression by Human Esophageal Epithelial CellsThe American Journal of Pathology, 2011
- A striking local esophageal cytokine expression profile in eosinophilic esophagitisJournal of Allergy and Clinical Immunology, 2011
- Relationships Between Eosinophilic Inflammation, Tissue Remodeling, and Fibrosis in Eosinophilic EsophagitisImmunology and Allergy Clinics of North America, 2009
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cellsJournal of Experimental Medicine, 2008
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesJournal of Experimental Medicine, 2008
- Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced EosinophiliaGastroenterology, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007